Journal of Lipid Research, Vol 29, 431-441, Copyright © 1988 by Lipid Research, Inc.

ARTICLES

Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats

J Bar-Tana, G Rose-Kahn, B Frenkel, Z Shafer and M Fainaru
Department of Biochemistry, Jerusalem, Israel.

Treatment of normal or puromycin aminonucleoside-nephrotic rats, kept on a balanced Purina chow diet, with beta, beta'-tetramethyl- substituted hexadecanedioic acid (MEDICA 16) (Bar-Tana, J., G. Rose- Kahn, and M. Srebnik. 1985. J. Biol. Chem. 260: 8404-8410) resulted in an acute reversible inhibition of liver lipogenesis and cholesterogenesis with a concomitant hypolipidemic effect which was sustained as long as the drug was administered. The hypolipidemic effect in normal and nephrotic rats consisted of 70-80% and 40-60% reduction in plasma VLDL-triacylglycerols and cholesterol, respectively, with a respective increase in the HDL-cholesterol/(VLDL + LDL)-cholesterol ratio. The observed hypolipidemic effect was accompanied by a 10-fold decrease in VLDL-apoC-III content with a concomitant enrichment of the VLDL fraction by VLDL remnants having an increased apoB-100/apoB-48 ratio. The pharmacological reduction of VLDL by MEDICA 16 may offer a treatment mode of choice for selected hyperlipidemic states.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Kalderon, V. Sheena, S. Shachrur, R. Hertz, and J. Bar-Tana Modulation by nutrients and drugs of liver acyl-CoAs analyzed by mass spectrometry J. Lipid Res., July 1, 2002; 43(7): 1125 - 1132. [Abstract] [Full Text] [PDF]

				E. D. Breyer, N.-A. Le, X. Li, D. Martinson, and W. V. Brown Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size J. Lipid Res., October 1, 1999; 40(10): 1875 - 1882. [Abstract] [Full Text]

				A.-M. Lefebvre, J. Peinado-Onsurbe, I. Leitersdorf, M. R. Briggs, J. R. Paterniti, J.-C. Fruchart, C. Fievet, J. Auwerx, and B. Staels Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1756 - 1764. [Abstract] [Full Text]

				J. C. Russell, R. M. Amy, S. E. Graham, P. J. Dolphin, G. O. Wood, and J. Bar-Tana Inhibition of Atherosclerosis and Myocardial Lesions in the JCR:LA-cp Rat by ß,ß'-Tetramethylhexadecanedioic Acid (MEDICA 16) Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 918 - 923. [Abstract] [Full Text]

				R. H. J. B.-S. and Jacob Bar-Tana and R. Hertz Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs J. Biol. Chem., June 2, 1995; 270(22): 13470 - 13475. [Abstract] [Full Text] [PDF]